apomorphine has been researched along with MPTP Neurotoxicity Syndrome in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 11 (57.89) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elliott, RB; Faull, RL; Geaney, MS; Law, L; Lee, JE; Lin, H; Luo, XM; Shaikh, SB; Skinner, SJ; Tan, PL; Waldvogel, H; Wang, W; Wynyard, S | 1 |
Fisher, R; Jackson, MJ; Jenner, P; Lees, AJ; Lincoln, L; Neumeyer, J; Rose, S; Sromek, AW | 1 |
Alberts, JL; Ghosh, D; Johnson, MD; Mera, TO; Rothe, D; Vitek, J; Xu, W; Zhang, J | 1 |
Matsumura, M | 1 |
Büeler, H; Feldon, J; Leng, A; Paterna, JC; Weber, E | 1 |
Canteras, NS; Da Cunha, C; Ferro, MM; Hipólide, D; Martinez, GR; Tufik, S; Vital, MA; Wietzikoski, EC | 1 |
Oleshko, NN | 1 |
Crossman, AR; Page, RD; Sambrook, MA | 1 |
Herrero, MT; Laguna, J; Luquin, MR; Obeso, JA | 1 |
Crossman, AR; Graham, WC; Sambrook, MA | 1 |
Akai, T; Kuno, S; Mizuta, E; Yamaguchi, M | 1 |
Kreutz, MR; Sabel, BA; Schroeder, H; Schroeder, U | 1 |
Blanchet, PJ; Chase, TN; Konitsiotis, S | 1 |
Gentsch, C; Spooren, WP; Vassout, A; Waldmeier, P | 1 |
Gassen, M; Grünblatt, E; Mandel, S; Youdim, MB | 1 |
Eoh, W; Hong, SC; Kim, JH; Kim, JS; Lee, JI; Lee, WY; Nam, DH; Park, K; Shin, HJ | 1 |
Lawrence, MS; Redmond, DE | 1 |
Boyce, S; Clarke, CE; Crossman, AR; Luquin, R; Mitchell, IJ; Robertson, RG; Sambrook, MA | 1 |
Bédard, PJ; Filion, M; Tremblay, L | 1 |
3 review(s) available for apomorphine and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
Topics: Animals; Apomorphine; Aporphines; Behavior, Animal; Callithrix; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Male; MPTP Poisoning; Valerates | 2016 |
Experimental parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Apomorphine; Basal Ganglia; Bicuculline; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Agonists; Electrocoagulation; GABA Antagonists; Globus Pallidus; Humans; Models, Neurological; MPTP Poisoning; Muscle Rigidity; Neurotoxins; Parkinsonian Disorders; Primates; Substance-Related Disorders; Substantia Nigra; Tegmentum Mesencephali; Thalamus | 2001 |
Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity.
Topics: Animals; Antioxidants; Apomorphine; Free Radical Scavengers; Iron Chelating Agents; Mice; MPTP Poisoning; Neuroprotective Agents; Neurotoxins; Oxidopamine; Rats | 1999 |
16 other study(ies) available for apomorphine and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells.
Topics: Animals; Animals, Newborn; Apomorphine; Cell Transplantation; Choroid Plexus; Dopamine Agonists; Immunohistochemistry; Macaca mulatta; Male; Movement; MPTP Poisoning; Neostriatum; Nerve Net; Neurologic Examination; Parkinson Disease, Secondary; Posture; Recovery of Function; Rotation; Swine; Tyrosine 3-Monooxygenase | 2013 |
Objective quantification of arm rigidity in MPTP-treated primates.
Topics: Animals; Antiparkinson Agents; Apomorphine; Arm; Deep Brain Stimulation; Disease Models, Animal; Electromyography; Electronic Data Processing; Female; Macaca mulatta; MPTP Poisoning; Muscle Rigidity; Muscle, Skeletal; Range of Motion, Articular | 2009 |
DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Dependovirus; Dopamine; Genetic Therapy; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Oncogene Proteins; Peroxiredoxins; Protein Deglycase DJ-1; Substantia Nigra; Synaptic Transmission; Ubiquitin-Protein Ligases | 2007 |
Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.
Topics: Analysis of Variance; Animals; Apomorphine; Brain Damage, Chronic; Disease Models, Animal; Dopamine; Dopamine Agonists; Functional Laterality; Locomotion; Male; Motor Activity; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Rotation; Severity of Illness Index; Statistics, Nonparametric; Substantia Nigra | 2008 |
[The reversibility of a blockade of corticofugal pulse trains to the neurons of the caudate nucleus in cats evoked by the neurotoxin MPTP].
Topics: Action Potentials; Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine Antagonists; Electric Stimulation; Male; Microelectrodes; Motor Cortex; MPTP Poisoning; Neural Inhibition; Neurons; Reaction Time; Time Factors | 1994 |
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
Topics: Afferent Pathways; Animals; Apomorphine; Axonal Transport; Brain Mapping; Chorea; Dyskinesia, Drug-Induced; Dystonia; Globus Pallidus; Horseradish Peroxidase; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Stereotaxic Techniques; Thalamus; Wheat Germ Agglutinins | 1993 |
Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Behavior, Animal; Dopamine; Dopamine Agents; Drug Tolerance; Female; Macaca fascicularis; Male; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Psychomotor Performance | 1993 |
Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Caudate Nucleus; Dopamine Agents; Female; Infusions, Intravenous; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.
Topics: Aggression; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dopamine Agents; Haloperidol; Lisuride; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine D2; Time Factors | 1993 |
Amphetamine induces hypermotility in MPTP-lesioned mice.
Topics: Animals; Apomorphine; Cell Membrane; Corpus Striatum; Dextroamphetamine; Dopamine Agents; Dopamine Antagonists; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 1997 |
Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Topics: Animals; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 1997 |
Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Habituation, Psychophysiologic; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Receptors, Presynaptic; Sodium Chloride; Synapses | 1998 |
Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine.
Topics: Animals; Apomorphine; Dopamine Agonists; Male; MPTP Poisoning; Oxidopamine; Parkinsonian Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Substantia Nigra | 2001 |
MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.
Topics: Animals; Apomorphine; Blinking; Chlorocebus aethiops; Dopamine Agents; Haloperidol; Male; MPTP Poisoning; Oxazines; Parkinson Disease; Receptors, Dopamine; Substantia Nigra; Sulpiride | 1991 |
Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
Topics: Animals; Apomorphine; Deoxy Sugars; Deoxyglucose; Dystonia; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary | 1990 |
Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism.
Topics: Action Potentials; Animals; Apomorphine; Corpus Striatum; Electric Stimulation; Globus Pallidus; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary | 1989 |